Regenerative Medicine Venturing at the University-Industry Boundary: Implications for Institutions, Entrepreneurs, and Industry

被引:2
|
作者
Bock, Adam J. [1 ]
Johnson, David [2 ]
机构
[1] Univ Wisconsin Madison, Madison, WI 53706 USA
[2] Edinburgh Napier Univ, Sch Business, Edinburgh, Midlothian, Scotland
关键词
Commercialization; Entrepreneurship; Technology transfer; Venturing; Regenerative medicine; ITALIAN BIOTECHNOLOGY INDUSTRY; BUSINESS MODELS; TECHNOLOGY-TRANSFER; STEM-CELL; STAR SCIENTISTS; PATENT; COMMERCIALIZATION; PERFORMANCE; INNOVATION; POLICY;
D O I
10.1007/978-3-319-97421-7_12
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Regenerative medicine research at university laboratories has outpaced commercial activity. Legal, regulatory, funding, technological, and operational uncertainty have slowed market entry of regenerative medicine treatments. As a result, commercial development has often been led by entrepreneurial ventures rather than large biopharma firms. Translating regenerative medicine across the university-industry boundary links academic scientists, technology transfer organizations, funders, and entrepreneurs. Conflicting motivations among the participants may significantly hinder these efforts. Unproven downstream business models for regenerative medicine delivery further complicate the entrepreneurial process. This chapter explores the challenges associated with entrepreneurial activity commercializing regenerative medicine science developed at research institutions.
引用
收藏
页码:213 / 236
页数:24
相关论文
共 50 条